News

Shares of Teladoc Health fell more than 25% Thursday after the telehealth company missed second-quarter revenue expectations and cut its full-year sales forecast. The pain is concentrated in BetterHelp, Teladoc's therapy and psychiatry platform, where revenue fell 12% to $212.6 million. Teladoc has pushed BetterHelp users toward insurance-covered therapy instead of cash-pay sessions.

Teladoc Health (TDOC) reported a Q2 loss late Wednesday of $0.21 per diluted share, wider than a los

Digital medical services platform Teladoc Health (NYSE:TDOC) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 4% year on year to $606.9 million. Next quarter’s revenue guidance of $589 million underwhelmed, coming in 6.5% below analysts’ estimates. Its GAAP loss of $0.21 per share was 17.4% above analysts’ consensus estimates.

Teladoc Health stock is coming off a very steep 5 year decline. Current checks suggest the shares may now be trading below a reasonable estimate of intrinsic value, with both the Discounted Cash Flow (DCF) work and market based multiples pointing to upside at the recent US$9.36 close. Teladoc Health shareholders have seen the stock fall 93.8% over the past 5 years, which means any current valuation gap matters a lot for investors who are reassessing the long term case. The planned Teladoc...

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.

In late June 2026, Teladoc Health, Inc. was removed from multiple Russell growth and small-cap benchmarks after a period of flat sales and ongoing losses, even as it maintained a large global member base and expanded partnerships with Walmart and the National Basketball Players Association. At the same time, insider share sales, index removals and a risk-off reaction to rising bond yields contrasted with a separate view that Teladoc’s discounted cash flow valuation suggests its shares may be...

The latest trading day saw Teladoc (TDOC) settling at $8.48, representing a -2.42% change from its previous close.

Teladoc (TDOC) concluded the recent trading session at $7.81, signifying a +1.56% move from its prior day's close.

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Teladoc Health delivers virtual care worldwide; a key insider recently exited their stake, according to the latest SEC filing.

Hims & Hers (NYSE:HIMS) is dominating headlines this week because the GLP-1 darling just delivered one of the ugliest quarters in the telehealth sector’s short history, and bargain hunters are circling the wreckage. But here’s what you should actually be watching. The Q1 2026 release on May 11, 2026 was a fracture. EPS came in ... Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss. Here Is the Profitable Healthcare Stock to Own Instead

Teladoc Health posts a y/y narrower Q1 loss and beats revenue estimates as international growth and cost cuts offset BetterHelp weakness and subscription declines.

Digital medical services platform Teladoc Health (NYSE:TDOC) announced better-than-expected revenue in Q1 CY2026, but sales fell by 2.5% year on year to $613.8 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $611.5 million was less impressive, coming in 2% below expectations. Its GAAP loss of $0.36 per share was 4.7% below analysts’ consensus estimates.